4558.T
CHUKYO IYAKUHIN CO.,LTD.
スタンダード · 医薬品 · 医薬品 · JP
JPY 202.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +4.2%
- EBITDA
- —
- EBIT
- +19.8%
- EPS
- +84.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -3.8%
- EBITDA
- —
- EPS
- -9.7%
Three-year CAGR
- Revenue
- +4.9%
- EBITDA
- +15.3%
- EBIT
- +29.1%
- Net income
- +81.0%
- EPS
- +79.3%
- Free cash flow
- -13.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026